No Data
Genvor Announces Strategic Memorandum of Understanding With Canlab International to Advance Commercial Peptide Pipeline
GENVOR INC | 10-Q/A: Quarterly report (Amendment)
Genvor, Inc. Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026
Express News | Genvor Announces Strategic Expansion Into Health and Wellness Market, Leveraging Proprietary AI-Accelerated Biocypher Platform to Develop Consumer Peptide Solutions
Genvor's AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event